HAZLET, N.J. - June 30, 2026 - PRLog -- In this educational initiative, HF expert faculty members will explain the evidence with sMRAs in HFrEF, discuss the limitations associated with utilization of sMRA therapy, describe the distinct profiles of sMRAs and nsMRAs, and interpret clinical evidence with sMRAs and nsMRAs in HFmrEF and HFpEF. A case study will provide attendees with best practices in overcoming challenges of diagnosing HFpEF, identify "pillars" of therapy, and describe keys to their effective and safe implementation.
Click here for more information
CHAIR
Javed Butler, MD, MPH, MBA
President, Baylor Scott & White Research Institute
Dallas, Texas
Distinguished Professor of Medicine
University of Mississippi
Jackson, Mississippi
FACULTY
Stephen Greene, MD
Associate Professor of Medicine
Duke University School of Medicine
Duke Clinical Research Institute
Durham, North Carolina
Muthiah Vaduganathan, MD, MPH
Co-Director, Center for Cardiometabolic Implementation Science
Assistant Professor of Medicine
Mass General Brigham and Harvard Medical School
Boston, Massachusetts
Orly Vardeny, PharmD, MS
Minneapolis VA Center for Care Delivery and Outcomes Research
Professor of Medicine
University of Minnesota
Minneapolis, Minnesota
Educational Objectives
- Describe the mechanisms of action of mineralocorticoid receptor antagonists (MRAs)
- Discuss the evidence for steroidal MRAs (sMRAs) in HFrEF and the challenges associated with their use
- Explain similarities and differences between nonsteroidal MRAs (nsMRAs) and sMRAs
- Interpret the clinical trial evidence for sMRAs and nsMRAs in patients with HFmrEF and HFpEF
- Indicate best practices for the diagnosis and treatment of patients with HFpEF
Target Audience
This program is intended for clinicians who manage patients with heart failure.
Accreditation and Credit Designation Statements
Voxmedia, LLC is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
Voxmedia, LLC designates this live activity for a maximum of 1.0 AMA PRA Category Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Nurse practitioners may participate in this educational activity and earn a certificate of completion as AANP accepts AMA PRA Category 1 Credits™ through its reciprocity agreements.
The National Commission on Certification of Physician Assistants accepts AMA PRA Category 1 Credits™ from organizations accredited by the ACCME.
Photos: (Click photo to enlarge)
Source: CMEPlanet
Read Full Story - 2026 HFM CME Symposium - Mineralocorticoid Receptor Antagonists in Heart Failure: The Evolving Treatment Landscape | More news from this source
Press release distribution by PRLog
